S Brian Wilson
Overview
Explore the profile of S Brian Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1092
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Exley M, Wilson S, Balk S
Curr Protoc Immunol
. 2017 Nov;
119:14.11.1-14.11.20.
PMID: 29091262
This unit details methods for the isolation, in vitro expansion, and functional characterization of human iNKT cells. The term 'iNKT' derives from the fact that a large fraction of murine...
2.
Kyriakakis E, Cavallari M, Andert J, Philippova M, Koella C, Bochkov V, et al.
Eur J Immunol
. 2010 Nov;
40(11):3268-79.
PMID: 21061446
Atherosclerosis, a chronic inflammatory lipid storage disease of large arteries, is complicated by cardiovascular events usually precipitated by plaque rupture or erosion. Inflammation participates in lesion progression and plaque rupture....
3.
Thayer T, Wilson S, Mathews C
Endocrinol Metab Clin North Am
. 2010 Aug;
39(3):541-61.
PMID: 20723819
In 1922, Leonard Thompson received the first injections of insulin prepared from the pancreas of canine test subjects. From pancreatectomized dogs to the more recent development of animal models that...
4.
Lombardi V, Stock P, Singh A, Kerzerho J, Yang W, Sullivan B, et al.
J Immunol
. 2010 Jan;
184(4):2107-15.
PMID: 20083656
The prevalence of asthma continues to increase in westernized countries, and optimal treatment remains a significant therapeutic challenge. Recently, CD1d-restricted invariant NKT (iNKT) cells were found to play a critical...
5.
Driver J, Scheuplein F, Chen Y, Grier A, Wilson S, Serreze D
Diabetes
. 2009 Nov;
59(2):423-32.
PMID: 19903740
Objective: In part, activation of invariant natural killer T (iNKT)-cells with the superagonist alpha-galactosylceramide (alpha-GalCer) inhibits the development of T-cell-mediated autoimmune type 1 diabetes in NOD mice by inducing the...
6.
Chopra P, DiIorio P, Pino S, Wilson S, Phillips N, Mordes J, et al.
In Vivo
. 2009 May;
23(2):195-201.
PMID: 19414403
Background: Alpha-galactosylceramide (alpha-GalCer) is an invariant natural killer T (iNKT) cell ligand that prevents type 1 diabetes in NOD mice. However, alpha-GalCer can activate or suppress immune responses, raising concern...
7.
Matangkasombut P, Marigowda G, Ervine A, Idris L, Pichavant M, Kim H, et al.
J Allergy Clin Immunol
. 2009 Apr;
123(5):1181-5.
PMID: 19356791
No abstract available.
8.
Blauvelt M, Khalili M, Jaung W, Paulsen J, Anderson A, Wilson S, et al.
Bioorg Med Chem Lett
. 2008 Nov;
18(24):6374-6.
PMID: 18993065
The synthesis and evaluation for iNKT stimulation of alpha-S-galactosylceramide is reported. Prepared by alkylation of a galactosylthiol, this analog of the potent immunostimulatory agent, KRN7000, did not stimulate iNKT cells...
9.
Exley M, Hou R, Shaulov A, Tonti E, Dellabona P, Casorati G, et al.
Eur J Immunol
. 2008 May;
38(6):1756-66.
PMID: 18493987
A significant fraction of CD1d-restricted T cells express an invariant T cell receptor (TCR) alpha-chain. These highly conserved invariant NKT (iNKT) populations are important regulators of a wide spectrum of...
10.
Exley M, Balk S, Wilson S
Curr Protoc Immunol
. 2008 Apr;
Chapter 14:Unit 14.11.
PMID: 18432899
Isolation and Functional Use of Human NK T Cells (Mark A. Exley andSteven P. Balk, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; S. Brian Wilson, Massachusetts...